Radionuclide-Labeled Antisilencing Function 1a Inhibitory Peptides for Tumor Identification and Individualized Therapy-Reference-Cited by-同舟云学术

Radionuclide-Labeled Antisilencing Function 1a Inhibitory Peptides for Tumor Identification and Individualized Therapy

Published:2024-03-13 Issue:12 Volume:18 Page:9114-9127
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Shi Xiumin¹²,Liu Teng¹^ORCID,Pei Pei¹,Shen Wenhao¹,Hu Lin¹^ORCID,Zhu Ran¹^ORCID,Wang Feng²,Chen Chunying³^ORCID,Yang Kai¹^ORCID

Affiliation:

1. State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215123, China

2. Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China

3. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China

Funder

National Key Research and Development Program of China

Jiangsu Provincial Department of Science and Technology

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Suzhou Medical College, Soochow University

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c00081

Reference37 articles.

1. Immune Checkpoint Blockade in Cancer Therapy

2. Immune checkpoint signaling and cancer immunotherapy

3. Monitoring immune-checkpoint blockade: response evaluation and biomarker development

4. Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy

5. Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity